Graham Parry
CIK: 0002153366
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ETRA
Electra Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Parry Graham
Parry Graham (SEC CIK 0002153366) files insider reports with the SEC as Principal Accounting Officer of Electra Therapeutics, Inc. (ETRA).
Signal8 holds 3 ownership filings by Parry Graham (2 Form 3, 1 Form 4), filed between Sep 18, 2026 and Sep 21, 2026. Those filings report 1 transaction, the latest on Sep 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Parry Graham's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Parry Graham
- Sep 21, 2026: Conversion of ETRA shares (Form 4, code C).
Other insiders filing for Electra Therapeutics, Inc. (ETRA)
- GORDON CARL L, Director
- ORBIMED ADVISORS LLC, Director
- Westlake BioPartners Fund I, L.P., 10% Owner
- Koe Gary S., Chief Technical Officer
- Stagliano Nancy, Director
- Dong Quehuong (Kathy), President & CEO